EP 1755607 A2 20070228 - COMPOSITIONS AND TREATMENTS FOR INHIBITING KINASE AND/OR HMG-COA REDUCTASE
Title (en)
COMPOSITIONS AND TREATMENTS FOR INHIBITING KINASE AND/OR HMG-COA REDUCTASE
Title (de)
ZUSAMMENSETZUNGEN UND BEHANDLUNGEN ZUR HEMMUNG VON KINASE UND/ODER HMG-COA-REDUKTASE
Title (fr)
COMPOSITIONS ET TRAITEMENTS POUR L'INHIBITION DE KINASE ET/OU DE HMG-COA REDUCTASE
Publication
Application
Priority
- US 2005014843 W 20050429
- US 56711804 P 20040429
- US 63068404 P 20041123
- US 63068304 P 20041123
Abstract (en)
[origin: WO2005115397A2] The present invention provides compositions of matter, kits and methods for their use in the treatment of kinase-related conditions and/or HMG-CoA reductase-related conditions. In particular, the invention provides compositions for treating immuno-compromised and/or cardiovascular conditions in an animal subject by modulating one or more MAP kinase(s) and/or HMG-CoA reductase, as well as providing formulations and modes of administering such compositions. The invention further provides methods for the rational design of modulators of MAP kinases, HMG-CoA reductase, or both for use in the practice of the present invention.
IPC 8 full level
A23L 15/00 (2016.01); C07D 239/42 (2006.01); A61K 31/4178 (2006.01); A61K 31/4439 (2006.01); A61K 31/506 (2006.01)
CPC (source: EP)
A61K 31/4178 (2013.01); A61K 31/4439 (2013.01); A61K 31/506 (2013.01); A61P 29/00 (2017.12); A61P 43/00 (2017.12)
Citation (search report)
See references of WO 2006028524A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR LV MK YU
DOCDB simple family (publication)
WO 2005115397 A2 20051208; WO 2005115397 A3 20060713; EP 1755607 A2 20070228; JP 2007535558 A 20071206; WO 2006028524 A2 20060316; WO 2006028524 A3 20090423
DOCDB simple family (application)
US 2005014833 W 20050429; EP 05818178 A 20050429; JP 2007511020 A 20050429; US 2005014843 W 20050429